Drug Screening
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FA7014 AFDW PK
Contract Value
Not provided
Codes & Classification
Solicitation Number
FA701426RAFDW
NAICS
621511 - Medical Laboratories
Classification Code
Q301
Additional Details
Documents3
The Air Force District of Washington, Contracting Directorate (AFDW/PK), located at Joint Base Andrews, Maryland, has issued a Sources Sought notice to conduct market research for civilian drug testing services in support of the United States Space Force (USSF) Drug Screening program. This initiative seeks to identify qualified businesses capable of providing comprehensive drug screening solutions for USSF personnel, with the place of performance specified as Washington, District of Columbia.
The scope of this procurement centers on medical laboratory services, as indicated by the NAICS code 621511 (Medical Laboratories) and Product Service Code Q301. The intended outcome is to ensure the USSF maintains a robust and reliable drug screening program for its civilian workforce, supporting the organization's commitment to a drug-free environment and compliance with federal regulations.
Key requirements include the ability to deliver professional drug testing services, which may encompass specimen collection, laboratory analysis, and reporting of results. The notice has undergone two amendments: the first extended the response deadline to allow vendors additional time to address questions, and the second provided the Government’s responses to vendor inquiries, demonstrating a commitment to transparency and thorough market engagement.
The contracting entity for this opportunity is FA7014 AFDW PK, a federal office under the Department of Defense and the Department of the Air Force. The primary point of contact is Sonya Rayford Cage, who can be reached via email at [email protected] for further information or clarification.
This procurement is currently in the market research phase, as indicated by its Sources Sought status, and is not yet a solicitation for bids or proposals. Contractors interested in this opportunity should review the attached documents and amendments for additional context and requirements. There are no explicit set-aside requirements or special considerations mentioned in the notice at this stage.
The opportunity remains active, with a response deadline of February 13, 2026. Interested parties are encouraged to visit the official SAM.gov listing (https://sam.gov/opp/b4225f2f67cc48bab2241da6e9560262/view) for further details and to access the three available attachments. This notice provides a valuable opportunity for medical laboratory service providers to support the USSF’s drug screening program and contribute to the integrity of its civilian workforce.